Quotient amends IPO

Transfusion diagnostics company Quotient Ltd. (Penicuik, U.K.) amended its IPO and now plans to sell 5 million units at $8 on NASDAQ, which would raise $40 million. Each unit comprises a share and a warrant to purchase 0.8 shares, with each whole warrant exercisable through October 2015 at $8.80. Earlier this month, Quotient said it planned to sell 5 million shares at $9-$11; the company would have raised $50 million at the $10 midpoint. UBS; Baird; and Cowen are underwriters. ...